Stock listing

OTC:CNBX CNBX Pharmaceuticals Inc. Stock

Follow CNBX Pharmaceuticals Inc. into a list and get an email when it puts out news.

Share price · OTC:CNBX

$0.0002 USD +0.0001 (+100.0%)

Close on Nov 2, 2026

Past year -33.3% · daily closes, Nov 3, 2025 – Nov 2, 2026, adjusted for splits
Day range
$0.0002 – $0.0002 USDNov 2, 2026
Volume
990,000 sharesNov 2, 2026
Market cap
$321,154 USDAt the close on Nov 2, 2026 · price × 1.61B shares outstanding
52-week range
$0.0001 – $0.0007 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
Traded on an average day
$743 USDMedian day 1.26M shares · 5 days with no trades · last 3 months, Aug 3, 2026 – Nov 2, 2026
CNBX Pharmaceuticals Inc. logo

Daily closes

Last 3 months, Aug 3, 2026 – Nov 2, 2026 · OTC:CNBX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.0002+0.0001+100.0%$0.0002$0.0002$0.0002990,000
$0.00010.00000.0%$0.0001$0.0001$0.000114,490,001
$0.00010.00000.0%$0.0001$0.0001$0.00012,050,000
$0.00010.00000.0%$0.0001$0.0001$0.000119,778,316
$0.00010.00000.0%$0.0002$0.0002$0.000170,035,912
$0.00010.00000.0%$0.0001$0.0001$0.00011,176
$0.0001-0.0001-50.0%$0.0001$0.0001$0.0001750,094
$0.00020.00000.0%$0.0002$0.0002$0.0002533,554
$0.0002+0.0001+100.0%$0.0002$0.0002$0.00026,500,000
$0.0001-0.0001-50.0%$0.0002$0.0002$0.000112,950,035
$0.00020.00000.0%$0.0002$0.0002$0.000225,507
$0.00020.00000.0%$0.0002$0.0002$0.00022,604,532
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.0002127,581
$0.00020.00000.0%$0.0002$0.0002$0.000231,340,050
$0.00020.00000.0%$0.0002$0.0002$0.00026,870,029
$0.0002+0.0001+100.0%$0.0002$0.0002$0.000230,275,020
$0.00010.00000.0%$0.0002$0.0002$0.0001855,250
$0.00010.00000.0%$0.0001$0.0001$0.0001500,001
$0.00010.00000.0%$0.0001$0.0001$0.00016,470,011
$0.0001-0.0001-50.0%$0.0001$0.0001$0.00011,059,970
$0.0002+0.0001+100.0%$0.0001$0.0002$0.0001520,058
$0.00010.00000.0%$0.0002$0.0002$0.00013,245,000
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.0001510,000
$0.0001-0.0001-50.0%$0.0002$0.0002$0.00015,715,001
$0.0002+0.0001+100.0%$0.0001$0.0002$0.000113,875,321
$0.00010.00000.0%$0.0001$0.0001$0.00017,980,132
$0.00010.00000.0%$0.0002$0.0002$0.00011,260,187
$0.00010.00000.0%$0.0001$0.0001$0.00011,432,444
$0.00010.00000.0%$0.0001$0.0001$0.00014,440,000
$0.00010.00000.0%$0.0001$0.0001$0.00014,510,002
$0.00010.00000.0%$0.0001$0.0001$0.00011,611,008
$0.00010.00000.0%$0.0001$0.0001$0.00012,762,800
$0.00010.00000.0%$0.0001$0.0001$0.00011,600,025
$0.00010.00000.0%$0.0001$0.0001$0.0001619,841
$0.00010.00000.0%$0.0001$0.0001$0.000134,569,524
$0.00010.00000.0%$0.0001$0.0001$0.000120,469,523
$0.0001-0.0001-50.0%$0.0001$0.0001$0.00012,000,049
$0.0002+0.0001+100.0%$0.0002$0.0002$0.000210,121
$0.0001-0.0001-50.0%$0.0002$0.0002$0.00011,936,017
$0.0002+0.0001+100.0%$0.0002$0.0002$0.0002525,556
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0002$0.0002$0.0001225,003
$0.0001-0.0001-50.0%$0.0002$0.0002$0.00015,770,000
$0.00020.00000.0%$0.0001$0.0002$0.000110,710,018
$0.00020.00000.0%$0.0001$0.0002$0.0001504,936
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.000280,023
$0.0002+0.0001+100.0%$0.0001$0.0002$0.00014,985,004
$0.00010.00000.0%$0.0002$0.0002$0.00012,241,006
$0.00010.00000.0%$0.0002$0.0002$0.0001429,417
$0.0001-0.0001-50.0%$0.0002$0.0002$0.0001209,064
$0.0002+0.0001+100.0%$0.0002$0.0002$0.000260,002
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.0001-0.0001-50.0%$0.0001$0.0001$0.00013,066,391
$0.0002+0.0001+100.0%$0.0002$0.0002$0.00014,137,084
$0.0001-0.0001-50.0%$0.0001$0.0001$0.0001500,002
$0.00020.00000.0%$0.0002$0.0002$0.0002100,001
$0.0002+0.0001+100.0%$0.0002$0.0002$0.0001660,403
$0.00010.00000.0%$0.0001$0.0001$0.000185,065
$0.00010.00000.0%$0.0001$0.0002$0.0001115,038
$0.00010.00000.0%$0.0001$0.0001$0.00011,010,166
Ticker
OTC:CNBX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

Latest news

CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma

Nov 8, 2022

CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy

Oct 18, 2022

CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel

Oct 13, 2022

CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for CNBX Proprietary Drug Candidate

Sep 29, 2022

CNBX Pharmaceuticals Announces New Patent Granted in Australia

Sep 28, 2022

CNBX Pharmaceuticals Release a New Corporate Presentation

May 31, 2022

CNBX Pharmaceuticals Granted Patent in Hong Kong

May 5, 2022

Cannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals

Mar 28, 2022

CNBX Selects API Supplier Purisys to Support Planned IND Fillings and Phase I/II (a) Clinical Trials

Nov 4, 2021

Meet CNBX at Radiation Therapy Conference (RTC) 2021 in Chicago

Oct 26, 2021

All CNBX Pharmaceuticals Inc. news

CNBX Pharmaceuticals Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
140 in all · newest Nov 8, 2022 · oldest 2011

Log in to ask 6ix AI your own questions about CNBX Pharmaceuticals Inc.